Robin Garner

Stock Analyst at Craig-Hallum

(0.81)
# 3,612
Out of 4,789 analysts
4
Total ratings
25%
Success rate
-8.8%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Robin Garner

Xeris Biopharma Holdings
Aug 28, 2023
Initiates: Buy
Price Target: $4.5
Current: $5.08
Upside: -11.42%
Cue Biopharma
Mar 18, 2022
Maintains: Buy
Price Target: $28$26
Current: $0.75
Upside: +3,366.67%
Fennec Pharmaceuticals
Apr 21, 2021
Initiates: Buy
Price Target: $17
Current: $5.53
Upside: +207.41%